Biotech · Private company
Lyvgen Biopharma Holdings Limited
Track this companyFree. Adds Lyvgen Biopharma Holdings Limited to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- KEYTRUDA® (pembrolizumab)Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- LVGN6051Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- LVGN7409Phase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsPHASE1 · TERMINATED · started Nov 12, 2021ClinicalTrials.gov NCT05075993 · fetched Nov 12, 2026
- Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic MalignancyPHASE1 · COMPLETED · started Dec 11, 2020ClinicalTrials.gov NCT04635995 · fetched Nov 12, 2026
- Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic MalignancyPHASE1 · COMPLETED · started Oct 31, 2019ClinicalTrials.gov NCT04130542 · fetched Nov 12, 2026